ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED

Company number 10138701

Date	Type	Description	View / Download
12 Jan 2022	TM01	Termination of appointment of Michael Irvine Mortimer as a director on 14 December 2021	(1 page)
11 Jan 2022	AP01	Appointment of Mr Joshua Hollis Korth as a director on 14 December 2021	(2 pages)
24 Sep 2021	TM01	Termination of appointment of John David Gillie as a director on 10 August 2021	(1 page)
26 May 2021	CS01	Confirmation statement made on 20 April 2021 with updates	(4 pages)
26 Nov 2020	TM01	Termination of appointment of Bruno Serge Leon Ladriere as a director on 4 November 2020	(1 page)
26 Nov 2020	TM01	Termination of appointment of Benjamin Maurice Frederick Witcher as a director on 4 November 2020	(1 page)
26 Nov 2020	TM01	Termination of appointment of Daniel Jacques Joseph Alexandre Setton as a director on 4 November 2020	(1 page)
24 Nov 2020	SH01	Statement of capital following an allotment of shares on 10 November 2020 USD 262,766,211.64	(3 pages)
19 Nov 2020	AP01	Appointment of Andrea Ponti as a director on 4 November 2020	(2 pages)
19 Nov 2020	AP01	Appointment of Mr Michael Irvine Mortimer as a director on 4 November 2020	(2 pages)
12 Nov 2020	MR01	Registration of charge 101387010003, created on 10 November 2020	(28 pages)
12 Nov 2020	MR01	Registration of charge 101387010004, created on 10 November 2020	(32 pages)
10 Nov 2020	MR01	Registration of charge 101387010002, created on 4 November 2020	(28 pages)
03 Oct 2020	AA	Audit exemption subsidiary accounts made up to 31 December 2019	(17 pages)
03 Oct 2020	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/19	(53 pages)
03 Oct 2020	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/19	(3 pages)
03 Oct 2020	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/19	(1 page)
30 Apr 2020	CS01	Confirmation statement made on 20 April 2020 with updates	(4 pages)
12 Jul 2019	AA	Audit exemption subsidiary accounts made up to 31 December 2018	(17 pages)
12 Jul 2019	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/18	(46 pages)
12 Jul 2019	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/18	(1 page)
12 Jul 2019	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/18	(3 pages)
21 Jun 2019	SH01	Statement of capital following an allotment of shares on 29 May 2019 USD 262,766,211.54	(4 pages)
01 May 2019	CS01	Confirmation statement made on 20 April 2019 with no updates	(3 pages)
13 Dec 2018	AP01	Appointment of Mr Benjamin Maurice Frederick Witcher as a director on 26 November 2018	(2 pages)